Quick Links

drugs

No increased heart failure with incretin-based drugs

McGill Newsroom

Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes medications

Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the New England Journal of Medicine.

Published: 24Mar2016